Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...
Classy move by the Tigers, honoring late sportswriter Pat Caputo with a moment of silence Friday night at Comerica Park.
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) stock is trading higher on Tuesday as the company is entering an exclusive global ...
Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed ...
SANTA MONICA, CALIFORNIA - JANUARY 04: Jackie Tohn attends the 31st Annual Critics Choice Awards at Barker Hangar on January ...
A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor ...
14h
Jackie Tohn Reveals She Had Double Mastectomy Due to Genetic Mutation — and Had Precancerous Cells
The “Nobody Wants This” actor initially struggled with the decision but is now raising awareness for genetic testing.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute ...
Even though Arvinas and Pfizer appear to have "written off" the drug, in one analyst's view, Rigel believes it can drive adoption among community-treated patients lacking SERD access.
After multiple doctor visits, she eventually got an MRI on Feb. 6. That same day, Charlie Hyser was admitted to Children's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results